Drugs

Drospirenone and Ethinyl Estradiol

Pharmacogenomic Information
  

 DrugTherapeutic Area*
Biomarker†
Referenced
Subgroup
 
Labeling Sections
Drospirenone and
Ethinyl Estradiol
Gynecology, Dermatology
CYP2C19
CYP2C19
intermediate
metabolizers
Clinical Pharmacology
 

 

* Therapeutic areas do not necessarily reflect the CDER review division.
 
† Standard nomenclature is used for genes as per the Human Genome Organization symbol, cytogenetic abnormalities as per the International System for Human Cytogenetic Nomenclature, or other conventions.

 

back to Table of Pharmacogenomic Biomarkers in Drug Labels

Page Last Updated: 03/17/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.